Medico Intercontinental Ltd (MIL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Medico Intercontinental Ltd on NSE and BSE, with an AI summary of each filing.
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve and take on record ....
Intimation · 06 Nov 2026, 5:30 am
Medico Intercontinental Schedules Board Meeting on 6th Nov'26 for Q2 Financial Results Medico Intercontinental Limited has scheduled a Board of Directors meeting on 6th Nov'26 to consider, approve, and take on record the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed for designated persons and insiders since 30th Sep'26 and will remain closed until 48 hours after the declaration of the financial results.
Submission of Scrutinizer''s report and voting results of 42nd AGM of the Company held on September 30, 2026.
Annual General Meeting · 02 Oct 2026, 4:16 pm
Proceedings of the 42nd Annual General Meeting of the Company held on 30 September, 2026.
Annual General Meeting · 30 Sept 2026, 8:39 pm
Notice of the 42nd Annual General Meeting of the Company to be held on 30th September, 2026.
Annual General Meeting · 05 Sept 2026, 7:20 pm
Reg. 34(1) Annual Report
Others (Uncategorized) · 05 Sept 2026, 7:12 pm
Results for the Quarter ended 30 June 2026
Financial Result · 14 Aug 2026, 10:05 pm
Medico Intercontinental Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 2,071 (-3.0% YoY | -7.9% QoQ) ■ EBITDA: -69.0 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -3.3 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: -145 (-113.4% YoY | -121.6% QoQ) ■ EPS (INR): -1.45 (-113.2% YoY | -123.1% QoQ)
Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company ....
Outcome · 14 Aug 2026, 9:59 pm
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve and take on record ....
Intimation · 14 Aug 2026, 5:30 am
Medico Intercontinental Board Meeting Set for Q1 Results Medico Intercontinental Ltd. has scheduled a Board of Directors meeting for 14th Aug'26. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Jun'26. In line with regulations, the trading window for designated persons and insiders has been closed since 30th Jun'26 and will reopen 48 hours after the results are declared.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Shah & PACs
Acquisition/ Disposal of Shares · 25 Jun 2026, 7:33 pm
Promoter Group Increases Stake in Medico Intercontinental Samir Dilipkumar Shah, Promoter & MD of Medico Intercontinental, acquired 1,36,886 equity shares (1.37% stake) via open market purchase from 3rd Jun'26 to 24th Jun'26. This transaction increased his personal holding from 46.40% to 47.78%. Consequently, the total promoter and PAC holding in the company has risen from 59.11% to 60.48%, consolidating their control. The acquisition underscores promoter confidence in the company. The total voting capital of the company stands at 10,00,00,000 shares.
Submission of Disclosure
Others (Uncategorized) · 25 Jun 2026, 7:15 pm
Promoter & MD Acquires 1,36,886 Shares via Open Market Purchase Medico Intercontinental's Promoter and Managing Director, Samir Dilipkumar Shah, acquired 1,36,886 equity shares via open market purchases. The transactions occurred between 3rd Jun'26 and 24th Jun'26. This acquisition has increased his total shareholding in the company. The company disclosed this insider transaction to the exchanges on 25th Jun'26, in compliance with SEBI's insider trading regulations.
Intimation of Re-appointment of an Internal Auditors.
Others (Uncategorized) · 22 May 2026, 6:52 pm
Medico Intercontinental Re-appoints Internal Auditor for FY27 Medico Intercontinental's Board of Directors approved the re-appointment of M/s. MJV & Co, Chartered Accountants, as the company's Internal Auditor for the financial year 2026-27. The decision was made during the board meeting held on 22nd May'26. MJV & Co is an Ahmedabad-based firm with experience in internal, tax, and statutory audits for public and private companies. The appointed firm has no stated relationship with the company's directors.
Results for the quarter and financial year ended March 31, 2026
Financial Result · 22 May 2026, 6:45 pm
Medico Intercontinental Reports FY26 Consolidated Loss Amid Higher Expenses Medico Intercontinental reported a consolidated net loss of Rs. 1,098.04 lakhs for FY26, a significant decline from a profit of Rs. 505.73 lakhs in FY25. Revenue from operations fell 11.8% YoY to Rs. 8,408.41 lakhs. For Q4 FY26, the consolidated net loss was Rs. 233.25 lakhs compared to a profit of Rs. 116.77 lakhs YoY, with revenue up 5.7% to Rs. 2,248.53 lakhs. The board, at its meeting on 22 May'26, also approved the reappointment of M/s. MJV & Co as Internal Auditor.
Outcome of Board meeting dated May 22, 2026.
Outcome · 22 May 2026, 6:32 pm
Medico Intercontinental Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 2,249 (+6.3% YoY | +13.3% QoQ) ■ EBITDA: 161 (-17.1% YoY | +1.5% QoQ) ■ EBITDA Margin (%): 7.2 (-202 bps YoY | -83 bps QoQ) ■ PAT: -65.3 (Profit to Loss YoY | -199.9% QoQ) ■ EPS (INR): -0.65 (Profit to Loss YoY | -195.5% QoQ)
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve and take on record ....
Intimation · 22 May 2026, 5:30 am
Medico Intercontinental Board Meeting Scheduled for Q4 & FY26 Results Medico Intercontinental Ltd. has scheduled a Board of Directors meeting on 22nd May'26. The agenda includes the consideration and approval of the audited standalone and consolidated financial results for the quarter and financial year ending 31st Mar'26. The trading window for insiders, which closed on 01st Apr'26, will remain shut until 48 hours after the results are declared. This meeting is crucial for assessing the company's full-year and final quarter performance for FY26.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 08 Apr 2026, 4:00 pm
Medico Intercontinental States It Is Not a Large Corporate On 8th Apr'26, Medico Intercontinental Ltd announced it does not qualify as a Large Corporate (LC) under SEBI's framework for mandatory debt issuance. The company confirmed its outstanding borrowings were ₹18.00 Cr as of 31st Mar or 31st Dec, below the threshold required for LC classification. Consequently, the firm is not obligated to meet the specified fund-raising requirements through debt securities. The company reported no credit rating during the previous financial year.
Results for the quarter and nine months ended December 31, 2025.
Financial Result · 14 Feb 2026, 6:33 pm
Medico Intercontinental Q3FY26 Standalone Profit Rises 11.8% YoY Medico Intercontinental reported Q3FY26 standalone net profit of ₹61.15 lakhs, up 11.8% YoY from ₹54.66 lakhs. Revenue from operations for the quarter stood at ₹1275.12 lakhs, an 11.6% YoY increase. On a consolidated basis, the company posted a net loss of ₹165.29 lakhs versus a profit of ₹117.40 lakhs YoY, impacted by higher expenses. Consolidated revenue grew 7.7% YoY to ₹1984.84 lakhs. The group adopted the equity method for accounting for its joint venture, effective 01 Apr'25, with prior periods restated.
Results for the quarter and nine months ended December 31, 2025
Outcome · 14 Feb 2026, 6:29 pm
MEDICO INTERCONTINENTAL LIMITED - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) ■ Revenue: 1985 (+7.7% YoY | -2.7% QoQ) ■ EBITDA: 158 (-16.6% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 8.0 (-233 bps YoY | Loss to Profit QoQ) ■ PAT: -21.8 (Profit to Loss YoY | +86.8% QoQ) ■ EPS (INR): -0.22 (Profit to Loss YoY | +86.7% QoQ)
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve and take on record ....
Intimation · 14 Feb 2026, 5:30 am
Medico Intercontinental Sets Board Meeting for Q3 FY26 Results Medico Intercontinental Ltd. has scheduled a Board of Directors meeting for 14th Feb'26 to consider and approve its unaudited standalone and consolidated financial results for the quarter and nine months ended 31st Dec'25. The company confirmed its trading window for insiders has been closed since 31st Dec'25 and will remain closed for 48 hours after the results are declared.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Dilipkumar Shah & PACs
Acquisition/ Disposal of Shares · 26 Dec 2025, 8:49 pm
Medico Intercontinental: Promoter Samir Shah Acquires Additional 1.97% Stake Promoter Samir Dilipkumar Shah acquired 1,97,285 equity shares (1.97% of total capital) of Medico Intercontinental Ltd via an open market purchase on 24th Dec'25. This transaction increased his individual holding from 44.43% to 46.40%. Consequently, the total promoter and Persons Acting in Concert (PAC) holding in the company has risen from 57.11% to 59.08%. The acquisition was disclosed under SEBI's SAST Regulations, 2011.
Submission of Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Others (Uncategorized) · 26 Dec 2025, 6:22 pm
Promoter and MD Increases Stake via Open Market Purchase Medico Intercontinental's Promoter and Managing Director, Samir Dilipkumar Shah, acquired 197,285 equity shares via an open market purchase on 24th Dec'25. This transaction increased his holding from 4,442,828 shares (44.43%) to 4,640,113 shares (46.40%). The shares were bought on the BSE exchange. This disclosure was made under SEBI's insider trading regulations on 26th Dec'25. The transaction signals a consolidation of promoter holding and confidence in the company.
Results - Financial results for the quarter and half year ended September 30, 2025
Financial Result · 14 Nov 2025, 11:41 pm
Outcome of Board meeting held on November 14, 2025
Outcome · 14 Nov 2025, 11:37 pm
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Board Meeting Intimation ....
Intimation · 14 Nov 2025, 5:30 am
Announcement under Regulation 30 (LODR) - Annual General Meeting updates
Annual General Meeting · 01 Oct 2025, 11:52 pm
VOTING RESULTS ALONG WITH SCRUTINIZER REPORT
Annual General Meeting · 01 Oct 2025, 11:46 pm